Can-Fite Submits Protocol to U.S. FDA for Phase II Liver Cancer Study
April 29, 2014 at 07:24 AM EDT
Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that ...